Canada contrast and imaging agents in Interventional X-ray Market is expected to register a healthy a CAGR of 4.9% in the forecast period of 2019 to 2026. The new market report contains data for the historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices)

Major growing sectors under the market segmentation are as follows;

In agent type, iodinated contrast media are dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.
In application, cardiology is dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.
In end user, imaging centers is dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.

The key market players for Canada contrast and imaging agents in interventional X-ray market are listed below;

General Electric Company
BRACCO
Guerbet
Lantheus Medical Imaging, Inc.
FUJIFILM VisualSonics Inc.
Others